Advocacy

HomeAdvocacy ▶ Year in Advocacy: 2016
Year in Advocacy: 2016

Administration

This year brought a number of successes through the promulgation of federal regulatory policy, including:

  • The Department of Housing and Urban Developing making all federally owned multi-unit public housing smoke free
  • NHBLI’s effort to develop a National COPD Action Plan
  • FDA exerting its regulatory authority over all tobacco products including e-cigarettes, cigars, and hookahs
  • OSHA issuing a more protective standard for occupational to silica

Congress

The ATS Advocacy program has also been working hard in Congress to advocate for the ATS members and the patients we serve.  Congressional successes include:

  • Securing funding increases for federal research programs including NIH and VA
  • Enactment of the 21st Century Cures bill to accelerate the development and review of medical advances
  • Successfully opposing legislative riders to weaken and delay EPA’s authority to regulate air
  • Successfully opposing legislative riders to weaken FDA’s authority to regulate all tobacco products  
  • ATS members testifying before Congress in support of the EPA Clean Air standards
  • Successfully opposing legislation to reduce scientific expert input in the development of federal regulatory policy
  • Hosting multiple Congressional briefings on the value of federal support for respiratory research funding

Courts

The ATS has also pursued court action to promote lung health, both suing the federal government when they failed to take appropriate action and supporting federal agencies when their efforts to protect respiratory health have been challenged in court.  Our court actions include:

  • Suing FDA for their failure to issue a re-issue a final rule requiring graphic warning labels on all tobacco products
  • Supporting EPA’s authority to regulate carbon pollution emissions
  • Support EPA’s authority to regulate ozone pollution
  • Petitioning the court to reject tobacco industry harassment of tobacco control experts on federal advisory panels
Last Reviewed: January 2017